Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-06-23 | New | $26,692,799 | $26,692,799 | Equity Only | 06b | SEC link |
| 2025-01-02 | New | $14,500,000 | $14,500,000 | Equity Only | 06b | SEC link |
| 2024-08-12 | New | $14,200,000 | $14,200,000 | Equity Only | 06b | SEC link |
| 2024-01-22 | New | $35,010,120 | $35,010,120 | Equity Only | 06b | SEC link |
| 2019-09-16 | New | $26,859,292 | $26,859,292 | Equity Only | 06b | SEC link |
| 2016-02-18 | New | $8,135,820 | $8,135,820 | Equity Only | 06b | SEC link |
| Name | Role |
|---|---|
| Dikla Czaczkes Akselbrad | Executive |
| Yechezkel Barenholz | Director |
| Yossi Ben Amram | Director |
| Dikla Czaczkes Akselbrad | Executive |
| Nir Dror | Director |
| Noam Emanuel | Director, Executive |
| Eli Frydman | Director |
| Jacob Harel | Director |
| Dalit Hazan | Executive |
| Chaim Hurvitz | Director |
| Yitzchak Jacobovitz | Director |
| Itzhak Krinsky | Director |
| Eitan Kyiet | Director, Executive |
| Shaun Marcus | Executive |
| Jonny Missulawin | Executive |
| Shaul Mukhtar | Executive |
| Gerry Rubens | Director |
| Anat Tsour Segal | Director, Executive |
| Robert B. Stein | Director |
| Nurit Tweezer Zaks | Director |
| Ori Warshavsky | Executive |
| Amir Weisberg | Director, Executive |